LAI HUNG-CHENG has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV SHANDONG QILU HOSPITAL, ZHEJIANG PROV HOSPITAL TRADITIONAL CHINESE MEDICINE and CHINA-JAPAN FRIENDSHIP HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Taiwan | 2 | |
#3 | United States | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Malaysia | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Diagnosis and surgery | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lai Hung-Cheng | 15 |
#2 | Huang Rui-Lan | 2 |
#3 | Liao Yu-Ping | 2 |
#4 | Su Po-Hsuan | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018019294A1 | Methods for gynecologic neoplasm diagnosis | |
TW201718876A | Methods for making diagnosis and/or prognosis of neoplasm | |
WO2017067477A1 | Methods for making diagnosis and/or prognosis of gynecologic neoplasm | |
CN103429235A | Compounds used for treating cancer and use thereof | |
TW201208668A | Compounds for the treatment of cancer and its application | |
CA2722884A1 | Sampler | |
MY150689A | Cancer screening method |